Trombolisis intravenosa con rtPA en el Stroke Isquémico Agudo. Eficacia y seguridad del programa instalado en el Hospital Universitario de la Fundación Favaloro / Intravenous thrombolysis with recombinant tissue plasminogen activator in the acute ischemic stroke

The study of the National Institute of Neurological Disorders and Stroke (NINDS) proved that the use of the recombinant tissue plasminogen activator (rtPA) within the first 3 hours since the beginning of the symptomatology of the acute ischemis stroke (AIS) is as well safe as effective...These preliminary data reported in our study show that a strict protocol of thrombolysis IV with rtPA in AIS is feasible to be carried on with good results in a high complexity Center.